Algenex
Founded 2005 · 55 employees on LinkedIn · 1 known investors
Find your way into Algenex
Sign up to see every warm intro you have to Algenex
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Algenex team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Algenex develops proprietary baculovirus expression technologies and manufacturing processes for producing recombinant proteins used in pharmaceuticals and diagnostics. The company harnesses insect-based bioreactors to enable cost-effective, scalable production of complex protein-based products.
Investors · 1
Columbus Venture Partnerslisted by Columbus Venture PartnersValenciavia Jose Mesa · inferred
How we know: Columbus Venture Partners's portfolio page · algenex.com · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Algenex do?
- Algenex develops proprietary baculovirus expression technologies and manufacturing processes for producing recombinant proteins used in pharmaceuticals and diagnostics. The company harnesses insect-based bioreactors to enable cost-effective, scalable production of complex protein-based products.
- Who are Algenex's investors?
- Algenex's investors include Columbus Venture Partners.

